Subscribe: MedWorm: Drugs & Pharmacology
http://www.medworm.com/rss/medicalfeeds/specialities/Drugs-Pharmacology.xml
Added By: Feedage Forager Feedage Grade B rated
Language: English
Tags:
drug  fda drug  fda  new  pharmaceutical society  royal pharmaceutical  rxlist new  rxlist  source fda  source rxlist  source  updated 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: MedWorm: Drugs & Pharmacology

MedWorm: Drugs & Pharmacology News



MedWorm.com provides a medical RSS filtering service. Thousands of medical RSS feeds are combined and output via different filters. This feed contains the latest news in Drugs & Pharmacology



Last Build Date: Fri, 23 Feb 2018 05:40:55 +0100

 



Comunicado de la FDA sobre la seguridad de los medicamentos: FDA requiere cambio de color de parches analg ésicos Duragesic (fentanilo) para mayor seguridad y enfatiza que la exposición accidental a parches usados puede causar la muerte

Thu, 22 Feb 2018 20:22:00 +0100

El 23 de septiembre, 2013, La Administraci ón de Alimentos y Medicamentos de Estados Unidos (FDA por sus siglas en inglés) está exigiendo que se cambie el color en el texto de los parches analgésicos Duragesic (fentanilo) para que se puedan ver más fácilmente. (Source: FDA Center for Drug Evaluation and Research - What's New)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




FDA Drug Safety Communication: FDA review finds additional data supports the potential for increased long-term risks with antibiotic clarithromycin (Biaxin) in patients with heart disease

Thu, 22 Feb 2018 19:31:00 +0100

The U.S. Food and Drug Administration (FDA) is advising caution before prescribing the antibiotic clarithromycin (Biaxin) to patients with heart disease because of a potential increased risk of heart problems or death that can occur years later. Our recommendation is based on our review of the results of a 10-year follow-up study1 of patients with coronary heart disease from a large clinical trial2 that first observed this safety issue. (Source: FDA Center for Drug Evaluation and Research - What's New)



Incorporation of Physical-Chemical Identifiers into Solid Oral Dosage Form Drug Products for Anticounterfeiting

Thu, 22 Feb 2018 15:24:00 +0100

Pharmaceutical Quality/CMC (Source: FDA Center for Drug Evaluation and Research - What's New)



Immunogenicity Assessment for Therapeutic Protein Products

Thu, 22 Feb 2018 15:22:00 +0100

Clinical/Medical; Pharmaceutical Quality/CMC (Source: FDA Center for Drug Evaluation and Research - What's New)



CMC Postapproval Manufacturing Changes To Be Documented in Annual Reports

Thu, 22 Feb 2018 14:49:00 +0100

Pharmaceutical Quality/CMC (Source: FDA Center for Drug Evaluation and Research - What's New)



RPS Wales reiterates call for urgent action on care home antipsychotics

Thu, 22 Feb 2018 12:30:00 +0100

The Royal Pharmaceutical Society in Wales has welcomed the launch of a new 5 year Dementia Action Plan for Wales but continues to call for urgent action on the use of antipsychotic medication in care (Source: Royal Pharmaceutical Society News)

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




Class 2 Medicines Recall: Ventolin Accuhaler 200mcg and Seretide Accuhaler 50 microgram/250 microgram/dose inhalation powder, pre-dispensed

Thu, 22 Feb 2018 09:22:00 +0100

The Medicines and Healthcare Products Regulatory Agency (MHRA) has issued class 2 medicines recalls for Ventolin Accuhaler 200mcg and Seretide Accuhaler 50 microgram/250 microgram/dose inhalation powd (Source: Royal Pharmaceutical Society News)



Study finds racial differences in cure rates for Hepatitis C

Thu, 22 Feb 2018 05:00:00 +0100

(Wiley) In a large ethnically diverse group of patients seen at a community-based Veterans Affairs practice, cure rates for chronic hepatitis C were lower for African American individuals relative to White individuals, even when patients were receiving optimal therapies. The findings are published in Pharmacology Research& Perspectives. (Source: EurekAlert! - Medicine and Health)



RPS Antimicrobial Expert Advisory Group welcomes new Chair

Thu, 22 Feb 2018 00:00:00 +0100

We are delighted to announce that Dr Jacqueline Sneddon has been elected new Chair of the RPS Antimicrobial Expert Advisory Group (AEAG). Jacqueline responded to her election stating:“I am del (Source: Royal Pharmaceutical Society News)



Diltiazem Hydrochloride (New - Currently in Shortage)

Wed, 21 Feb 2018 18:00:00 +0100

Drug Shortage (Source: FDA Drug Shortages)



Organ-Specific Warnings: Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over-the-Counter Human Use —

Wed, 21 Feb 2018 16:26:00 +0100

Pharmaceutical Quality/CGMP; Compliance; Over-the-Counter (Source: FDA Center for Drug Evaluation and Research - What's New)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




Time and Extent Applications for Nonprescription Drug Products

Wed, 21 Feb 2018 16:18:00 +0100

Over-the-Counter (Source: FDA Center for Drug Evaluation and Research - What's New)



FDA Drug Safety Communication: FDA requiring color changes to Duragesic (fentanyl) pain patches to aid safety ―emphasizing that accidental exposure to used patches can cause death

Wed, 21 Feb 2018 13:56:00 +0100

The U.S. Food and Drug Administration (FDA) is requiring color changes to the writing on Duragesic (fentanyl) pain patches so they can be seen more easily. This is part of an effort to prevent accidental exposure to the patches, which can cause serious harm and death in children, pets, and others.   (Source: FDA Center for Drug Evaluation and Research - What's New)



Vancomycin Hydrochloride (Vancomycin Hydrochloride Injection) - updated on RxList

Wed, 21 Feb 2018 07:00:00 +0100

(Source: RxList - New and Updated Drug Monographs)



ParaGard (Intrauterine Copper Contraceptive) - new on RxList

Wed, 21 Feb 2018 07:00:00 +0100

(Source: RxList - New and Updated Drug Monographs)



Vecuronium Bromide (Vecuronium Bromide Injection, Powder, Lyophilized, for Solution) - new on RxList

Wed, 21 Feb 2018 07:00:00 +0100

(Source: RxList - New and Updated Drug Monographs)

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




Erleada (Apalutamide Tablets) - new on RxList

Wed, 21 Feb 2018 07:00:00 +0100

(Source: RxList - New and Updated Drug Monographs)



Symdeko (Tezacaftor/Ivacaftor Tablets and Ivacaftor Tablets) - new on RxList

Wed, 21 Feb 2018 07:00:00 +0100

(Source: RxList - New and Updated Drug Monographs)



Postmarketing Adverse Event Reporting for Nonprescription Human Drug Products Marketed Without an Approved Application

Tue, 20 Feb 2018 19:50:00 +0100

Over-the-Counter (Source: FDA Center for Drug Evaluation and Research - What's New)



Organ-Specific Warnings: Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over-the-Counter Human Use — Small Entity Compliance Guide

Tue, 20 Feb 2018 19:48:00 +0100

Over-the-Counter; Small Entity Compliance Guides (Source: FDA Center for Drug Evaluation and Research - What's New)



Label Comprehension Studies for Nonprescription Drug Products

Tue, 20 Feb 2018 18:45:00 +0100

Over-the-Counter (Source: FDA Center for Drug Evaluation and Research - What's New)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




Lidocaine Hydrochloride Injection (New - Currently in Shortage)

Tue, 20 Feb 2018 17:00:00 +0100

Drug Shortage (Source: FDA Drug Shortages)



Bupivacaine Hydrochloride Injection, USP (New - Currently in Shortage)

Tue, 20 Feb 2018 17:00:00 +0100

Drug Shortage (Source: FDA Drug Shortages)



Bupivacaine Hydrochloride and Epinephrine Injection, USP (New - Currently in Shortage)

Tue, 20 Feb 2018 17:00:00 +0100

Drug Shortage (Source: FDA Drug Shortages)



New committee to examine safety, rationality of over 300 drugs banned since 2016

Tue, 20 Feb 2018 14:46:36 +0100

The committee will be headed by Dr Nilima Kshirsagar, chair of clinical pharmacology at the Indian Council of Medical Research, Mumbai, according to the notification. (Source: The Economic Times Healthcare and Biotech News)



RPS England urges community pharmacists to take up training

Tue, 20 Feb 2018 12:20:00 +0100

Community pharmacists in Englandcan now enrol on free training at Masters level through thePharmacy Integration Fund. You can choose to take a single or range of modules and learning will encompass f (Source: Royal Pharmaceutical Society News)

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




Xofigo (Radium Ra 223 Dichloride) - updated on RxList

Tue, 20 Feb 2018 07:00:00 +0100

(Source: RxList - New and Updated Drug Monographs)



Potency of delta-9 -tetrahydrocannabinol and other cannabinoids in cannabis in England in 2016: implications for public health and pharmacology. - Potter DJ, Hammond K, Tuffnell S, Walker C, Di Forti M.

Mon, 19 Feb 2018 18:03:30 +0100

BACKGROUND: In 2005 and 2008, studies reported that cannabis in England had become dominated by the sinsemilla (unseeded female) form. The average potency ( Δ9-tetrahydrocannabinol [THC] content) of this material had doubled over the previous decade. Canna... (Source: SafetyLit)



RPS England talks to BBC's Look North about reimbursement

Mon, 19 Feb 2018 11:45:00 +0100

The Drug Tariff sets the price for the majority of items prescribed on the NHS by GPs in order to incentivise efficient purchasing. However, fluctuations in the prices of prescription medicines cause (Source: Royal Pharmaceutical Society News)



FDA Approves Osmolex ER (amantadine) for the treatment of Parkinson ’s Disease and Drug-Induced Extrapyramidal Reactions

Mon, 19 Feb 2018 05:02:18 +0100

BRIDGEWATER, N.J., Feb. 19, 2018 (GLOBE NEWSWIRE) -- Osmotica Pharmaceutical US LLC ( “Osmotica” or the “Company”), a privately-held specialty pharmaceutical company developing novel central nervous system (CNS) treatments utilizing its... (Source: Drugs.com - New Drug Approvals)



Ketamine Injection (New - Currently in Shortage)

Fri, 16 Feb 2018 18:00:00 +0100

Drug Shortage (Source: FDA Drug Shortages)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




Dorzolamide Hydrochloride Ophthalmic Solution (Updated - Currently in Shortage)

Fri, 16 Feb 2018 18:00:00 +0100

Drug Shortage (Source: FDA Drug Shortages)



Bactrim vs. Cipro

Fri, 16 Feb 2018 07:00:00 +0100

Title: Bactrim vs. CiproCategory: MedicationsCreated: 2/16/2018 12:00:00 AMLast Editorial Review: 2/16/2018 12:00:00 AM (Source: MedicineNet Medications General)



Histological Disease Severity in Lean Patients With NAFLD Histological Disease Severity in Lean Patients With NAFLD

Fri, 16 Feb 2018 05:15:15 +0100

How do histological features associated with disease severity differ in lean-NAFLD versus overweight/obese-NAFLD patients?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)



FDA Expands Approval of Imfinzi (durvalumab) to Reduce the Risk of Non-Small Cell Lung Cancer Progressing

Fri, 16 Feb 2018 01:02:46 +0100

February 16, 2018 -- The U.S. Food and Drug Administration today approved Imfinzi (durvalumab) for the treatment of patients with stage III non-small cell lung cancer (NSCLC) whose tumors are not able to be surgically removed (unresectable) and... (Source: Drugs.com - New Drug Approvals)



UCLA scientists receive $7.7 million grant to study HIV recurrence

Fri, 16 Feb 2018 00:07:06 +0100

The virus that causes AIDS is known to hide in certain rare cells. When people with HIV stop taking their medications, the virus can re-emerge and multiply, or “rebound,” from those hiding places. To better combat HIV, scientists have been working to understand how and why the virus re-emerges.“It’s the resurrection of virus that you couldn’t see in the body before,” said Jerome Zack, professor of medicine and chair of the UCLA department of microbiology, immunology and molecular genetics at the David Geffen School of Medicine at UCLA. Zack, who is director of the  UCLA Center for AIDS Research, and colleagues recently received a grant from the National Institute of Allergy and Infectious Diseases called “Defining Factors Controlling HIV Rebound.” The five-year, $7.7 mill...

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




Join us at the online hustings for the RPS National Pharmacy Board Elections 2018

Thu, 15 Feb 2018 15:49:00 +0100

As this year’s RPS National Pharmacy Board Elections are fast approaching, we would like to invite you to our online hustings. This year, we are going to host them online via a Telegram group. (Source: Royal Pharmaceutical Society News)



Omnaris (Ciclesonide Nasal Spray) - updated on RxList

Thu, 15 Feb 2018 07:00:00 +0100

(Source: RxList - New and Updated Drug Monographs)



Cyanokit (Hydroxocobalamin for Injection) - updated on RxList

Thu, 15 Feb 2018 07:00:00 +0100

(Source: RxList - New and Updated Drug Monographs)



Acetazolamide Injection (Acetazolamide Injection) - updated on RxList

Thu, 15 Feb 2018 07:00:00 +0100

(Source: RxList - New and Updated Drug Monographs)



Pediapred (Prednisolone Sodium) - updated on RxList

Thu, 15 Feb 2018 07:00:00 +0100

(Source: RxList - New and Updated Drug Monographs)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




Tymlos (Abaloparatide Injection) - updated on RxList

Thu, 15 Feb 2018 07:00:00 +0100

(Source: RxList - New and Updated Drug Monographs)



Metabolomics, a promising tool for advancing in treatment personalization of oncological patients

Thu, 15 Feb 2018 05:00:00 +0100

(Bentham Science Publishers) This review provides specific examples of metabolomics applications in the field of clinical pharmacology and precision medicine with a focus on the therapeutic management of cancer and in the translation of these results to the clinics. (Source: EurekAlert! - Cancer)



FDA Approves Erleada (apalutamide) for Non-Metastatic Castration-Resistant Prostate Cancer

Wed, 14 Feb 2018 20:02:32 +0100

February 14, 2018 -- The U.S. Food and Drug Administration today approved Erleada (apalutamide) for the treatment of patients with prostate cancer that has not spread (non-metastatic), but that continues to grow despite treatment with hormone... (Source: Drugs.com - New Drug Approvals)



Deferoxamine Mesylate for Injection, USP (Updated - Currently in Shortage)

Wed, 14 Feb 2018 18:35:00 +0100

Drug Shortage (Source: FDA Drug Shortages)



Progesterone Injection, USP (Updated - Currently in Shortage)

Wed, 14 Feb 2018 18:35:00 +0100

Drug Shortage (Source: FDA Drug Shortages)

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




Methylphenidate Hydrochloride (QUILLICHEW ER) Extended-Release Chewable Tablets (Updated - Currently in Shortage)

Wed, 14 Feb 2018 18:35:00 +0100

Drug Shortage (Source: FDA Drug Shortages)



Public Health England: National Minimum Standards and Core Curriculum for Immunisation Training for Registered Healthcare Practitioners

Wed, 14 Feb 2018 11:40:00 +0100

Public Health England have issued guidance... (Source: Royal Pharmaceutical Society News)



RPS Wales welcomes £100m investment in care transformation

Wed, 14 Feb 2018 09:30:00 +0100

A recent announcement by the Welsh Government to invest£100m to transform the delivery of care in Wales has been warmly welcomed by RPS Wales. Responding to the announcement, Suzanne Scott-Thom (Source: Royal Pharmaceutical Society News)



RPS Wales welcomes £100m investment to transform care

Wed, 14 Feb 2018 09:30:00 +0100

A recent announcement by the Welsh Government to invest£100m to transform the delivery of care in Wales has been warmly welcomed by the Royal Pharmaceutical Society inWales. Responding to the (Source: Royal Pharmaceutical Society News)



Dispensing errors defence due in law in April

Wed, 14 Feb 2018 09:13:17 +0100

The Royal Pharmaceutical Society has welcomed the news that a new defence around inadvertent dispensing errors is one step closer to coming into force. The Pharmacy (Preparation and Dispensing Errors (Source: Royal Pharmaceutical Society News)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




Flo-Pred (Prednisolone Acetate Oral Suspension) - updated on RxList

Wed, 14 Feb 2018 07:00:00 +0100

(Source: RxList - New and Updated Drug Monographs)



Radiogenix System (Technetium Tc-99m Generator) - new on RxList

Wed, 14 Feb 2018 07:00:00 +0100

(Source: RxList - New and Updated Drug Monographs)



Dexycu (Dexamethasone Intraocular Suspension 9%, for Intraocular Administration) - new on RxList

Wed, 14 Feb 2018 07:00:00 +0100

(Source: RxList - New and Updated Drug Monographs)



Biktarvy (Bictegravir, Emtricitabine, and Tenofovir Alafenamide Tablets) - new on RxList

Wed, 14 Feb 2018 07:00:00 +0100

(Source: RxList - New and Updated Drug Monographs)



FDA Drug Safety Communication: Pradaxa (dabigatran etexilate mesylate) should not be used in patients with mechanical prosthetic heart valves

Tue, 13 Feb 2018 16:00:00 +0100

The U.S. Food and Drug Administration (FDA) is informing health care professionals and the public that the blood thinner (anticoagulant) Pradaxa (dabigatran etexilate mesylate) should not be used to prevent stroke or blood clots (major thromboembolic events) in patients with mechanical heart valves, also known as mechanical prosthetic heart valves. (Source: FDA Center for Drug Evaluation and Research - What's New)

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




Comunicado de la FDA sobre la seguridad de los medicamentos: Nuevo factor de riesgo para la leucoencefalopat ía multifocal progresiva (PML por sus siglas en inglés) relacionado con Tysabri (natalizumab)

Tue, 13 Feb 2018 15:16:00 +0100

El 20 de enero del 2012, la Administraci ón de Alimentos y Medicamentos de Estados Unidos (FDA por sus siglas en inglés) informó al público que ha identificado como factor de riesgo para la leucoencefalopatía multifocal progresiva (PML por sus siglas en inglés) la detección en pruebas de anticuerpos contra el virus JC. PML es una in fección poco común pero grave del cerebro relacionada con el uso de Tysabri (natalizumab) para el tratamiento de esclerosis múltiple o enfermedad de Crohn. (Source: FDA Center for Drug Evaluation and Research - What's New)



FDA Drug Safety Communication: UPDATE on Tumor Necrosis Factor (TNF) blockers and risk for pediatric malignancy

Tue, 13 Feb 2018 12:55:00 +0100

[11-03-2011] The U.S. Food and Drug Administration (FDA) is updating the public about its ongoing safety review of Tumor Necrosis Factor (TNF) blockers and malignancy (cancer) in children, adolescents, and young adults (30 years of age or younger). (Source: FDA Center for Drug Evaluation and Research - What's New)



Sudafed (Pseudoephedrine) - updated on RxList

Tue, 13 Feb 2018 07:00:00 +0100

(Source: RxList - New and Updated Drug Monographs)



Pain Therapeutics Resubmits New Drug Application for Remoxy ER, an Abuse-Deterrent, Extended-Release Drug Candidate for the Treatment of Chronic Pain

Tue, 13 Feb 2018 06:02:13 +0100

AUSTIN, Texas, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq:PTIE) announced today the resubmission to the U.S. Food and Drug Administration (FDA) of a New Drug Application (NDA) for Remoxy ER, its lead drug candidate. The... (Source: Drugs.com - New Drug Applications)



Trump Budget Ups Funds to Fight Opioids, Cuts HHS Trump Budget Ups Funds to Fight Opioids, Cuts HHS

Tue, 13 Feb 2018 02:28:20 +0100

The budget takes a four-pronged approach, according to the new HHS secretary, with the fight against opioid abuse gaining some funding, while other departments may take some hits for 2019.Medscape Medical News (Source: Medscape Pharmacist Headlines)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




FDA Approves Symdeko (tezacaftor/ivacaftor and ivacaftor) to Treat Cystic Fibrosis in People Ages 12 and Older with Certain Mutations in the CFTR Gene

Mon, 12 Feb 2018 20:02:26 +0100

BOSTON--(BUSINESS WIRE) Feb 12, 2018 -- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) approved Symdeko (tezacaftor/ivacaftor and ivacaftor) for treating the underlying cause of... (Source: Drugs.com - New Drug Approvals)



RPS in England advises the public to think 'pharmacy first' for minor health concerns

Mon, 12 Feb 2018 16:26:00 +0100

Today NHS Englandlaunched‘Stay Well Pharmacy’, a major new national media campaign to raise awareness and promote the use of community pharmacy for clinical advice for minor health concer (Source: Royal Pharmaceutical Society News)



RPS advises the public to think 'pharmacy first' for minor health concerns

Mon, 12 Feb 2018 16:26:00 +0100

Today NHS Englandlaunched‘Stay Well Pharmacy’, a major new national media campaign to raise awareness and promote the use of community pharmacy for clinical advice for minor health concer (Source: Royal Pharmaceutical Society News)



Esmya (ulipristal acetate) for uterine fibroids: monitor liver function in current and recent users; do not initiate treatment in new users or those between treatment courses

Mon, 12 Feb 2018 15:16:00 +0100

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a letter to healthcare professionals: Esmya (ulipristal acetate) for uterine fibroids: monitor liver function in current and r (Source: Royal Pharmaceutical Society News)



Prandimet (Repaglinide and Metformin HCl Tablets) - updated on RxList

Mon, 12 Feb 2018 07:00:00 +0100

(Source: RxList - New and Updated Drug Monographs)

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




Kyleena (levonorgestrel) - updated on RxList

Mon, 12 Feb 2018 07:00:00 +0100

(Source: RxList - New and Updated Drug Monographs)



U.S., EU and Japan Health Authorities Accept Regulatory Submissions For Review Of Pfizer ’s Third-generation ALK Inhibitor Lorlatinib

Mon, 12 Feb 2018 05:02:31 +0100

February 12, 2018 - Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration (FDA) accepted and granted Priority Review to the company ’s New Drug Application for lorlatinib. Lorlatinib is an investigational, anaplastic... (Source: Drugs.com - New Drug Applications)



Icon Bioscience Receives FDA Approval for Dexycu (dexamethasone intraocular suspension) for Treating Inflammation Associated With Cataract Surgery

Mon, 12 Feb 2018 03:02:55 +0100

Newark, CA (February 12, 2018) – Icon Bioscience, Inc. (IBI), a specialty biopharmaceutical company focused on utilizing its Verisome® drug-delivery platform to develop unique intraocular eye-care therapeutics, today announced that the United... (Source: Drugs.com - New Drug Approvals)



Efficacy of Fecal Microbiota Transplant in Refractory UC Efficacy of Fecal Microbiota Transplant in Refractory UC

Fri, 09 Feb 2018 17:00:00 +0100

Could the microbial composition of donor stools influence why some therapy refractory ulcerative colitis patients respond well to fecal transplantation, while others do not?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)



RPS in Scotland welcomes funding for dedicated posts for care home pharmacists in England but urges quicker progress in Scotland

Fri, 09 Feb 2018 15:04:00 +0100

Earlier this week, NHS England announced that the Pharmacy Integration Fund will be used to fund 180 pharmacists and 60 pharmacy technician posts to help improve medicines optimisation (pharmaceutical (Source: Royal Pharmaceutical Society News)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




NHS England vaccine ordering for 2018-19 influenza season

Fri, 09 Feb 2018 13:49:00 +0100

NHS England have shared letters have with... (Source: Royal Pharmaceutical Society News)



FDA Drug Safety Communication: Safety review update of Chantix (varenicline) and risk of neuropsychiatric adverse events

Fri, 09 Feb 2018 13:18:00 +0100

[10-24-2011] The U.S. Food and Drug Administration (FDA) has reviewed the results from two FDA-sponsored epidemiological studies that evaluated the risk of neuropsychiatric adverse events associated with the smoking cessation drug Chantix (varenicline). (Source: FDA Center for Drug Evaluation and Research - What's New)



FDA Drug Safety Communication: Safety review update on the possible increased risk of blood clots with birth control pills containing drospirenone

Fri, 09 Feb 2018 13:15:00 +0100

[09-26-2011] The U.S. Food and Drug Administration (FDA) is informing the public that it has not yet reached a conclusion, but remains concerned, about the potential increased risk of blood clots with the use of drospirenone-containing birth control pills. (Source: FDA Center for Drug Evaluation and Research - What's New)



Drug safety update: Mycophenolate mofetil, mycophenolic acid: updated contraception advice for male patients

Fri, 09 Feb 2018 10:22:00 +0100

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a drug safety update: Mycophenolate mofetil, mycophenolic acid: updated contraception advice for male patients. It is now reco (Source: Royal Pharmaceutical Society News)



Considerations for Statin Use, Toxicity, and Interactions Considerations for Statin Use, Toxicity, and Interactions

Fri, 09 Feb 2018 05:14:54 +0100

This brief primer gives an overview of the specific pharmacology for the various statin drugs, their adverse effects, and potential for drug interactions.Southern Medical Journal (Source: Medscape Today Headlines)

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




Device that measures cell strength could help identify drugs for asthma, hypertension and muscular dystrophy

Fri, 09 Feb 2018 00:29:00 +0100

Engineers, doctors and scientists at UCLA and Rutgers University have developed a tool that measures the physical strength of individual cells 100 times faster than current technologies.The new device could make it easier and faster to test and evaluate new drugs for diseases associated with abnormal levels of cell strength, including hypertension, asthma and muscular dystrophy. It could also open new avenues for biological research into cell force. It is the first high-throughput tool that can measure the strength of thousands of individual cells at a time.“Our tool tracks how much force individual cells exert over time, and how they react when they are exposed to different compounds or drugs,” said Dino Di Carlo, professor of bioengineering at theUCLA Henry Samueli School of Engineer...



Avoiding Adverse Drug Interactions Can Prevent Hospitalizations in...

Fri, 09 Feb 2018 00:00:00 +0100

Twice as many patients aged 65 years and older are hospitalized because of problems related to an adverse drug reaction than younger patients, according to the...(PRWeb February 09, 2018)Read the full story at http://www.prweb.com/releases/2018/02/prweb15183047.htm (Source: PRWeb: Medical Pharmaceuticals)



Zytiga (abiraterone acetate) Plus Prednisone Approved for Treatment of Earlier Form of Metastatic Prostate Cancer

Thu, 08 Feb 2018 22:02:20 +0100

HORSHAM, PA, Feburary 8, 2018 – The Janssen Pharmaceutical Companies of Johnson& Johnson today announced that the U.S. Food and Drug Administration (FDA) has approved a new indication for Zytiga (abiraterone acetate) in combination with... (Source: Drugs.com - New Drug Approvals)



Dorzolamide Hydrochloride and Timolol Maleate (Cosopt) Ophthalmic Solution (Updated - Currently in Shortage)

Thu, 08 Feb 2018 18:16:00 +0100

Drug Shortage (Source: FDA Drug Shortages)



Videx EC (Didanosine Delayed-Release Capsules) - updated on RxList

Thu, 08 Feb 2018 07:00:00 +0100

(Source: RxList - New and Updated Drug Monographs)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




Tobacco giant's research largesse ignites controversy

Thu, 08 Feb 2018 00:00:00 +0100

(Source: ScienceNOW)



FDA Approves Biktarvy (bictegravir, emtricitabine, tenofovir alafenamide) for Treatment of HIV-1 Infection

Wed, 07 Feb 2018 21:02:07 +0100

FOSTER CITY, Calif.--(BUSINESS WIRE)--Feb. 7, 2018-- Gilead Sciences, Inc. (NASDAQ:GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved Biktarvy (bictegravir 50mg/emtricitabine 200mg/tenofovir alafenamide 25mg,... (Source: Drugs.com - New Drug Approvals)



FDA Drug Safety Communication: Update to ongoing safety review of Lantus (insulin glargine) and possible risk of cancer

Wed, 07 Feb 2018 13:10:00 +0100

[1-12-2011] The U.S. Food and Drug Administration (FDA) is updating the public about its ongoing safety review of Lantus (insulin glargine) and a possible increased risk of cancer. (Source: FDA Center for Drug Evaluation and Research - What's New)



Balcoltra (Levonorgestrel and Ethinyl Estradiol and Ferrous Bisglycinate Tablets ) - new on RxList

Wed, 07 Feb 2018 07:00:00 +0100

(Source: RxList - New and Updated Drug Monographs)



Firvanq (Vancomycin Hydrochloride for Oral Solution) - new on RxList

Wed, 07 Feb 2018 07:00:00 +0100

(Source: RxList - New and Updated Drug Monographs)

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




Lutathera (Lutetium Lu 177 dotatate Injection ) - new on RxList

Wed, 07 Feb 2018 07:00:00 +0100

(Source: RxList - New and Updated Drug Monographs)



Verastem Submits NDA to FDA for Duvelisib for the Treatment of Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and Follicular Lymphoma

Wed, 07 Feb 2018 05:02:16 +0100

BOSTON--(BUSINESS WIRE)--Feb. 7, 2018-- Verastem, Inc. (NASDAQ: VSTM), focused on discovering and developing drugs to improve the survival and quality of life of cancer patients, today announced it has submitted a New Drug Application (NDA) to the... (Source: Drugs.com - New Drug Applications)



Re-introducing an 'old' antibiotic may help fight multi-drug resistant bacteria

Wed, 07 Feb 2018 05:00:00 +0100

(Wiley) A new study indicates that the drug fosfomycin may be effective for treating multidrug-resistant bacterial infections. In most European countries, the oral formulation is only approved as a 3 gram single dose for the treatment of uncomplicated cystitis; however the Pharmacology Research& Perspectives study found that a dosing regimen of 6-12 grams per day divided in 3 doses is required for the treatment of systemic multi-drug-resistant bacterial infections. (Source: EurekAlert! - Medicine and Health)



Remifentanil (Ultiva) Lyophilized Powder for Solution Injection (New - Currently in Shortage)

Tue, 06 Feb 2018 18:00:00 +0100

Drug Shortage (Source: FDA Drug Shortages)



Fluorescein Strips (New - Currently in Shortage)

Tue, 06 Feb 2018 18:00:00 +0100

Drug Shortage (Source: FDA Drug Shortages)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




Simvastatin (Zocor) Tablets (New - Discontinuation)

Tue, 06 Feb 2018 18:00:00 +0100

Drug Shortage (Source: FDA Drug Shortages)



Saquinavir Mesylate (Invirase) 200mg Capsules (New - Discontinuation)

Tue, 06 Feb 2018 18:00:00 +0100

Drug Shortage (Source: FDA Drug Shortages)



Simvastatin Tablets (New - Discontinuation)

Tue, 06 Feb 2018 18:00:00 +0100

Drug Shortage (Source: FDA Drug Shortages)



Our media highlights 2017

Tue, 06 Feb 2018 16:25:00 +0100

We make every effort to get pharmacists on TV and radio speaking up about medicines and patient care. So how often do pharmacists appear in the media? If they're a member talking on behalf of the (Source: Royal Pharmaceutical Society News)



Changes to Ribena

Tue, 06 Feb 2018 15:49:59 +0100

Lucozade Ribena Suntory (LRS) are reducing the sugar content of Ribena Blackcurrant (Ready To Drink and squash by approximately 55%). Pharmacists should be aware of this change as Ribena Blackcurrant (Source: Royal Pharmaceutical Society News)

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




Safe Use Initiative - Current Projects

Tue, 06 Feb 2018 15:35:00 +0100

Part of Safe Use Initiative (updated) (Source: FDA Center for Drug Evaluation and Research - What's New)



New Stay Well Pharmacy campaign

Mon, 05 Feb 2018 22:09:00 +0100

NHS England is launching a campaign to encourage people to use their local pharmacy as a first port of call for minor health concerns. Running from12th February to 31st March 2018the campaign aims to (Source: Royal Pharmaceutical Society News)



FDA Adverse Event Reporting System (FAERS) Public Dashboard

Mon, 05 Feb 2018 19:29:00 +0100

Four FAERS summary statistics reports updated with data through December 31, 2013. (Source: FDA Center for Drug Evaluation and Research - What's New)



Atropine Sulfate Injection

Mon, 05 Feb 2018 18:10:00 +0100

Drug Shortage (Source: FDA Drug Shortages)